Ashley Marton, M.D.C.M., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Hematologist and Medical Oncologist - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Ashley Marton, M.D.C.M., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Hematologist and Medical Oncologist

  • By

  • October 22, 2026

  • 2 min

Share

Clinical Scorecard: Ashley Marton, M.D.C.M., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Hematologist and Medical Oncologist

At a Glance

CategoryDetail
ConditionSolid tumors and hematologic conditions; clinical focus on breast, prostate and colon cancers
Key MechanismsNot described in the source
Target PopulationPatients treated by Dr. Marton for solid tumors or hematologic conditions
Care SettingLynn Cancer Institute, Boynton Beach, Florida, part of Baptist Health Cancer Care

Key Highlights

  • Ashley Marton, M.D.C.M., joined Lynn Cancer Institute as a hematologist and medical oncologist.
  • Her clinical focus includes breast, prostate and colon cancers, alongside a broad range of solid tumors and hematologic conditions.
  • She has served as a principal investigator and sub-investigator in oncology clinical trials.
  • Her care philosophy emphasizes collaboration, patient education and shared decision-making.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients treated by Dr. Marton for solid tumors or hematologic conditions at Lynn Cancer Institute.

          The source provides no medication or prescribing details. It states that Dr. Marton develops evidence-based, individualized treatment plans and is interested in integrating new cancer treatments into care.

          Clinical Best Practices

          • Dr. Marton describes her care philosophy as rooted in collaboration, patient education and shared decision-making.
          • She says she aligns clinical evidence with patients’ personal values, lifestyle and individual goals.
          • The source states that she has served as a principal investigator and sub-investigator in oncology clinical trials.

          Related Resources & Content

          Original Source(s)

          Related Content